There is no standard cannabis dosage for autism. No product is approved for autism, and no published guideline sets a milligram amount, a THC-to-CBD ratio, or a body-weight formula a family can use at home. The closest thing to a top pick is clinician-supervised titration with a CBD-dominant product from a licensed, lab-tested source, starting at the smallest measurable amount and adjusting slowly while tracking behavior in a written log. I compared the options below on four criteria: strength of published evidence, consistency of the product, THC exposure, and how easily a dose can be adjusted and monitored.
The short answer on dosage
Anyone who tells you there is a standard autism dose is guessing. Pediatric neurology and developmental medicine treat cannabinoids as an off-label experiment, not a treatment protocol. That means the dose is found by trial, in one patient at a time, with a prescriber who knows the child's other medications and seizures history. The dose that helps one child may do nothing for another and may cause sedation, appetite loss, or irritability in a third.
Two things are consistent across the literature: doses in studies were set by the study team and adjusted week by week, and no study has produced a dose that another clinic can copy. Any number you see online is either from a single small trial or invented.
THC for Autism: What the Evidence Shows and How to Approach It
What published trials actually did
Published research on cannabinoids for autism is small and mostly open-label. Trials have used oral CBD-rich extracts, often with a small amount of THC, given for weeks to months, with caregivers rating changes in aggression, anxiety, sleep, and social interaction. Several reported improvements on parent-rated scales. Few were randomized, almost none were blinded, and follow-up was short. A Cochrane review of cannabinoids for autism spectrum disorder concluded the evidence is not strong enough to support or rule out benefit for core symptoms.
That gap matters for dosing. Without controlled data, there is no way to say which dose produced which effect, or whether the effect came from the cannabinoid, the routine of giving it, or the family's expectations.
Option 1: CBD-dominant oral extract, clinician-supervised
This is the closest match to what has actually been studied. A high-CBD, low-THC oral oil, given under medical supervision, with the dose raised in small steps over weeks.
Pros
- Mirrors the product type used in most published pediatric autism trials
- Low THC load limits intoxication and reduces the psychiatric risk tied to adolescent THC exposure
- Liquid oil allows small, repeatable adjustments rather than jumping between fixed capsule strengths
- Lab-tested legal products let you verify CBD and THC content against the label
Cons
- Still off-label, with no guaranteed benefit and no timeline for one
- CBD can raise blood levels of some anti-seizure and psychiatric drugs through liver enzyme pathways
- Fatigue, appetite changes, and stomach upset are common reasons families stop
- Requires a cooperative patient, since oil is held under the tongue or swallowed
Use case: a child or teen with aggression, anxiety, or sleep disruption whose care team agrees to a monitored trial and who can be watched for side effects and drug interactions.
Option 2: THC-forward or balanced products
Products with meaningful THC, whether smoked, vaped, or taken as a balanced edible, are a different risk category. Some adults with autism report relief from anxiety or sensory overload. The evidence for children is thin, and the risk profile is not comparable to CBD-dominant oil.
Pros
- Faster onset when inhaled, which can help an adult manage an acute sensory or anxiety episode
- Some adults report better sleep and appetite than with CBD alone
- Wide product selection in legal markets
Cons
- Intoxication impairs judgment and coordination, and dosing by inhalation is hard to measure
- Regular THC use in adolescence is associated with cognitive and psychiatric harms
- Edible effects are delayed, which leads to repeat dosing and overshoot
- Little pediatric evidence, and no study supports this route as a first choice
Use case: adults with autism making their own informed decision, ideally with medical input, and not as a starting point for a minor.
Option 3: Prescription pharmaceutical CBD
One purified CBD product is FDA-approved, and only for specific severe seizure disorders, not autism. Some clinicians use it off-label in autistic patients who also have epilepsy.
Pros
- Pharmaceutical consistency: the same concentration in every bottle
- Clear prescribing record and pharmacy oversight
- Established safety data in children, including monitoring guidance
Cons
- Not indicated for autism, so coverage is often denied
- Costly without insurance approval
- Requires a willing prescriber and periodic liver monitoring
- Fixed formulation offers less room to fine-tune than a compounded oil
Use case: an autistic patient with a seizure disorder already being treated by a neurologist who is comfortable managing CBD.
How clinicians pick a starting point and titrate
- Review every current medication, especially anti-seizure and psychiatric drugs.
- Set a baseline: sleep hours, aggression counts, anxiety episodes, appetite.
- Begin at the lowest measurable amount, once or twice daily.
- Hold that amount for several days before changing anything.
- Increase in small steps no more often than the clinician directs, logging behavior daily.
- Stop and call the prescriber if sedation, rash, worsening behavior, or stomach symptoms appear.
Safety, interactions, and red flags
CBD interacts with drugs processed by liver enzymes, which includes several anticonvulsants and some antidepressants. Combining cannabis with sedatives adds to drowsiness. Inhaled cannabis is not appropriate for a child or teen. Seek urgent care for vomiting, confusion, severe drowsiness, or a seizure that lasts longer than usual. Never change a prescribed medication to make room for cannabis without telling the prescriber.
Bottom line
There is no cannabis dose for autism that you can look up. The realistic path is a licensed, lab-tested CBD-dominant oil, a prescriber who monitors the trial, a low start, slow increases, and a log that shows whether anything changed. THC-forward products carry risks that make them a poor choice for minors. Treat any specific milligram number you find online as unverified until the person prescribing it has seen your child's medication list.